Our Services
Medical Information
Helpful Resources
Published on: 5/22/2026
Find specialized chronic hives expertise through the UCARE network’s global centers, which offer multidisciplinary teams, advanced diagnostics, and access to cutting-edge therapies and clinical trials.
There are several factors to consider when selecting a UCARE center, from accreditation standards and personalized treatment plans to telemedicine options. See complete details below.
Chronic spontaneous urticaria (CSU), commonly called chronic hives, affects daily life through itchy welts and swelling that last more than six weeks. Finding expert care is key to controlling symptoms, minimizing flare-ups, and improving quality of life. The Urticaria Reference Centers of Excellence (UCARE network) brings together leading clinics worldwide dedicated to the diagnosis, treatment, and research of all forms of urticaria.
The UCARE network is a global consortium of specialized centers focused on urticaria. These centers:
By concentrating experience and resources, the UCARE network drives advances in understanding chronic hives and translates them into better patient outcomes.
Opting for a center within the UCARE network ensures access to:
These benefits translate into quicker symptom relief, fewer flare-ups, and improved day-to-day functioning.
UCARE centers adhere to a unified framework:
Accreditation
Research and Collaboration
Education and Outreach
This integrated approach ensures consistency in care and fosters innovation across regions.
To find the nearest urticaria reference center of excellence within the UCARE network:
Most centers offer telemedicine consultations, making high-quality care accessible even if you live far from a major city.
When you schedule an appointment at a UCARE center, anticipate:
Based on findings, your care team will develop a step-wise treatment plan aligned with international guidelines.
Chronic urticaria management often follows a stepwise algorithm:
UCARE centers monitor response closely, adjusting therapies to achieve symptom control with minimal side effects.
Participation in clinical trials at UCARE centers may offer early access to groundbreaking treatments. Ongoing studies investigate:
Discuss trial eligibility with your UCARE clinician to weigh potential benefits and risks.
If you're uncertain whether your symptoms align with chronic urticaria, consider using a free Medically approved LLM Symptom Checker Chat Bot to evaluate your symptoms and receive personalized guidance before scheduling a specialist visit. This intelligent tool can help clarify the urgency of your situation and recommend appropriate next steps.
While most urticaria cases are non-life-threatening, certain signs warrant prompt evaluation:
For any serious or potentially life-threatening concerns, speak to a doctor or visit your nearest emergency department without delay.
Living with chronic hives can be challenging, but partnering with a urticaria reference center of excellence in the UCARE network offers:
Working closely with your healthcare team and staying informed about advances in urticaria care will help you regain control over symptoms and enjoy a better quality of life.
Remember: Always discuss any new or worsening symptoms with your physician. For serious or life-threatening signs, seek urgent medical attention.
(References)
* Weller K, Zuberbier T, Maurer M. Urticaria Centers of Reference and Excellence (UCARE): A global network for urticaria research and care. J Allergy Clin Immunol Pract. 2021 Mar;9(3):1108-1117. doi: 10.1016/j.jaip.2020.10.046. Epub 2020 Nov 6. PMID: 33166779.
* Zuberbier T, Abdul Latiff AH, Abuzakouk M, et al. International Consensus on the Interdisciplinary Management of Urticaria. J Allergy Clin Immunol Pract. 2023 Mar;11(3):797-810. doi: 10.1016/j.jaip.2022.11.028. Epub 2022 Dec 15. PMID: 36528746.
* Zuberbier T, Abdul Latiff AH, Abuzakouk M, et al. The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria 2021 update. Allergy. 2022 Jan;77(1):7-33. doi: 10.1111/all.15093. Epub 2021 Oct 14. PMID: 34506540.
* Weller K, Zuberbier T, Maurer M. The Urticaria Patient Journey: A Global Perspective on Diagnosis and Treatment Challenges. J Allergy Clin Immunol Pract. 2020 Dec;8(10):3300-3310. doi: 10.1016/j.jaip.2020.06.020. Epub 2020 Jun 25. PMID: 32593818.
* Zuberbier T, Maurer M, Weller K, et al. Urticaria research agenda 2021: from new insights to new treatments. Allergy. 2021 Apr;76(4):1042-1060. doi: 10.1111/all.14722. Epub 2021 Jan 25. PMID: 33405072.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.